PsychPlus Harlingen Clinic - Psychiatrist and Therapist
3701 W Business 83, Harlingen
4.9(78 Google reviews)
United States
3 listed treatment centers serving Harlingen and the surrounding area.
3701 W Business 83, Harlingen
4.9(78 Google reviews)
For people in Harlingen, the cost of SPRAVATO® depends on insurance benefits, the treatment setting, and the services billed. The medication and the visit for supervised administration and monitoring may generate separate charges. Ask for an estimate that includes both, rather than a medication-only estimate.
Prior authorization and documentation of earlier antidepressant trials are common requirements. Your prescriber may need records showing which medications you tried and how you responded. Ask who gathers those records, who submits the authorization request, and whether approval is needed before your first appointment. Authorization does not necessarily mean every charge will be paid.
Medicare coverage may fall under Part B or Part D, depending on the plan and setting. Texas Medicaid coverage also depends on the plan and setting. The three Harlingen listings in this directory are marked as not accepting Medicare or Medicaid; confirm current participation directly before scheduling. These listings do not establish whether your insurance benefit covers treatment elsewhere.
Manufacturer savings programs exist for eligible commercially insured patients, not patients using government insurance. Eligibility restrictions apply, so ask about current terms rather than assuming assistance will be available.
Before starting, ask the center and your insurer:
Keep the center’s estimate and the insurer’s explanation for reference when reviewing bills.
SPRAVATO® treatment takes place only in a healthcare setting certified through the SPRAVATO® REMS program. You self-administer the nasal spray under a healthcare provider’s direct observation; it is never sent home. This directory lists three Harlingen locations offering treatment, but their REMS certification status is not recorded. Confirm certification directly before arranging care.
For treatment-resistant depression, the typical labeled schedule starts with twice-weekly visits during weeks 1–4, then weekly visits during weeks 5–8. Maintenance may be weekly or every two weeks. Your prescriber determines the schedule for your situation; do not assume visits will become less frequent on a fixed date.
Plan for more than a two-hour appointment. Monitoring alone lasts at least two hours after each dose, and check-in, preparation, and discharge assessment add time. Ask the center how much time to reserve and whether appointment times can fit around work or caregiving. Consider requesting recurring time off rather than arranging each absence separately.
You need someone else to drive you home. You must not drive or operate machinery until the next day after a restful sleep. Arrange a reliable ride and a backup, and ask the center about its pickup and escort requirements before relying on a hired ride.
If no Harlingen listing is available when you search, or local options cannot meet your needs, this directory also lists centers in San Antonio, Austin, Houston, Friendswood, Fort Worth, Dallas, El Paso, and McKinney. These are alternatives to investigate, not assurances of nearby access. Confirm certification, appointment availability, insurance participation, and a workable travel plan before committing.
This directory lists three Harlingen locations offering SPRAVATO®, but their REMS certification status is not recorded. Contact a location and ask whether it is currently certified to administer treatment through the REMS program. Also confirm whether it accepts new patients, works with your insurance, and offers appointment times you can attend consistently. A directory listing alone does not verify certification.
Spravato is approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved, together with an oral antidepressant, for depressive symptoms in adults with major depressive disorder and acute suicidal ideation or behavior. It is not approved for children. A clinician must review your symptoms, treatment history, and health risks to determine whether it is appropriate.
Coverage depends on your plan and the treatment setting. Prior authorization and records of earlier antidepressant trials are common requirements. Ask about coverage for both the medication and supervised monitoring visit. The three Harlingen listings are marked as not accepting Medicare or Medicaid, so confirm participation directly. A plan’s treatment benefit does not mean a particular center accepts that plan.
You use the nasal spray yourself under a healthcare provider’s direct observation in a REMS-certified setting. Staff monitor you for at least two hours after the dose, including for sedation, dissociation, breathing problems, and blood pressure increases. Your healthcare provider assesses when you can leave. Arrange a driver home, and do not drive or operate machinery until the next day after a restful sleep.
Important risks include sedation, dissociation—feeling disconnected from yourself or your surroundings—respiratory depression, and blood pressure increases. Spravato carries boxed warnings for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors. It is a Schedule III controlled substance. Review your medical history, medicines, and any substance-use concerns with your clinician before treatment.
No. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior, and it does not replace hospitalization when needed. If you are in crisis or having suicidal thoughts, call or text 988 for immediate support. If you are in immediate danger or have a medical emergency, call 911. Do not wait for a treatment appointment to seek help.
Approved uses, nearby treatment centers, and medically sourced patient guides.